A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes

Clinical trial NCT02846545 · COMPLETED

Trial details

NCT number: NCT02846545
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2016-08-26
Primary completion: 2019-05-21
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.